Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 232
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05832697 | An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers | ||
| NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT02952755 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20162 in Healthy Volunteers | ||
| NCT02947139 | Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers | ||
| NCT06119945 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult Volunteers | ||
| NCT04888715 | To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
| NCT06682000 | Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension | ||
| NCT02952547 | Safety and Pharmacokinetics Study of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT04767815 | To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers | ||
| NCT05389215 | Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF | ||
| NCT05812404 | Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy Subjects | ||
| NCT04888728 | To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers | ||
| NCT01094834 | A Multiple Dose Study of DWP05195 in Healthy Adult Subjects | ||
| NCT06736587 | Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Volunteers | ||
| NCT05660122 | A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab | ||
| NCT06437951 | to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection | ||
| NCT04634500 | The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes. | ||
| NCT04161001 | Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 | ||
| NCT03364985 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers | ||
| NCT06671392 | A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension | ||
| NCT06419816 | Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus | ||
| NCT03029533 | Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer | ||
| NCT04003441 | Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers | ||
| NCT01099891 | The Clinical Study for Evaluation of Efficacy and Safety of EGF on Oral Mucositis in Radiation Therapy Patients | ||
| NCT05500898 | Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male Adults | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT06399835 | Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis | ||
| NCT03184324 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study) | ||
| NCT04926623 | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) | ||
| NCT02947815 | Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm | ||
| NCT07256600 | PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers | ||
| NCT07558707 | Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World Practice | ||
| NCT02502721 | A Clinical Trial to Evaluate Pharmacokinetics and Safety Between DWC20151 and DWC20152 | ||
| NCT05149274 | Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects | ||
| NCT07144176 | PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers | ||
| NCT01415466 | Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers | ||
| NCT04713176 | Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients | ||
| NCT07746518 | Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive Esophagitis | ||
| NCT04772443 | Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507 | ||
| NCT04520022 | Safety and Effectiveness Study of Allogeneic Umbilical Cord Blood-derived Mesenchymal Stem Cell in Patients With RDEB | ||
| NCT06141980 | Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus | ||
| NCT06354127 | DWP450 for Treating Moderate to Severe Glabellar Lines | ||
| NCT03517319 | Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT01423526 | A Single Dose Study of DWP10292 in Healthy Male Subjects | ||
| NCT01397240 | The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients | ||
| NCT05614778 | Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis | ||
| NCT03736369 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) | ||
| NCT05184179 | Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab | ||
| NCT04654390 | The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus |
